While marketed as non-sedating, these medications can still cause drowsiness in some individuals and may interact with other medications
For others, those wins are more important than weight loss
Evans concluded that, There is an urgent need for studies that accurately measure muscle mass, strength, and mobility during GLP-1 agonistinduced weight loss and regain of weight after they are stopped, especially in older people. October 28, 2024: FDA Issues Warning About Using Compounded Semaglutide Drugs for Weight Loss In October, the FDA issued a warning to patients who take compounded GLP-1 drugs for weight loss
CJC-1295 + Ipamorelin vs Sermorelin, MK-677, and GHRP-2 Common GH-secretagogue alternatives Comparison Sermorelin (alone or with Ipamorelin) vs CJC-1295 + Ipamorelin Sermorelin is the original GHRH analog (FDA-approved 1997 for pediatric GH deficiency, withdrawn 2008)
1 Long MD, B, et al